At CPHI Worldwide 2026, Stoelzle presents enhanced EcoSecur with improved hydrolytic resistance 23.09.2026 Vienna, Austria, 21 September 2026 At CPHI Worldwide 2026, Stoelzle Glass Group will present the next evolution of EcoSecur, its Type 2 pharmaceutical glass packaging solution. Visitors to the Stoelzle booth can discover how the enhanced liquid-based inner-surface treatment process improves coating consistency and product performance and discuss current pharmaceutical packaging challenges directly with the company's experts. EcoSecur has been commercially available since 2021. Following several years of development, customer qualification and industrial validation, Stoelzle has further advanced the manufacturing process behind the established solution. More precise treatment for consistent performance Conventional manufacturing methods for Type II glass typically rely on gas- or pellet-based treatment processes. At its pharmaceutical glass production site, Stoelzle instead uses an internally developed liquid-injection process. The treatment solution is precisely dosed and adapted to each container size to ensure even distribution across the sidewalls and base. For pharmaceutical manufacturers, the result is a more homogeneous inner-surface treatment, improved hydrolytic resistance and greater production consistency - particularly relevant for sensitive injectable formulations, infusion therapies and other parenteral applications. For pharmaceutical customers, consistency and reliable packaging performance are essential. The enhanced treatment process allows us to further strengthen these qualities across a broad range of demanding applications,” says Antonia Karamat, Head of Stoelzle Medical & Global Sales Director Pharma A proven solution for pharmaceutical applications EcoSecur is produced from Type 3 soda-lime pharmaceutical glass with an inner-surface treatment that gives containers Type II performance. It is available globally in flint and amber glass, in formats from 7 ml to 500 ml, and complies with European and US pharmacopoeia requirements. EcoSecur is suitable for pharmaceutical applications in both human and veterinary medicine, including injection vials and infusion bottles for parenteral medicines, contrast media, pain therapies, plasma and infusion therapies. For us, innovation is not only about developing new products. It is also about continuously improving proven solutions to create additional value for our customers. The latest evolution of EcoSecur reflects this approach and our long-term commitment to pharmaceutical glass packaging,” says Alexander Stern, CSCO Stoelzle Glass Group & Head of Healthcare Business Unit Supporting resource-efficient manufacturing The precise dosing approach is also designed to support resource-efficient production by applying only the amount of treatment solution required for each container. This can help reduce material use and waste, while automated process controls support consistent production and employee safety. Meet Stoelzle at CPhI Worldwide 2026 CPHI Worldwide 2026 takes place from 6 to 8 October in Milan. Throughout the exhibition, Stoelzle's pharmaceutical packaging specialists will be available at booth 11C74 (hall H11) to showcase the company's latest developments in pharmaceutical glass packaging, including the latest advancement of EcoSecur. EVENT CPHI 2026 6-8 October Milan, Italy VISIT STOELZLE Booth: 11C74 - Hall H11 Fiera Milano Meet the EcoSecur experts
